Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO).
Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that Al Ford is joining the company ...
Israeli macrophage reprogramming immunotherapy company Enlivex Therapeutics (ENLV) announced “highly positive” clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback